CerbACT Asia Holds Ribbon Cutting to Celebrate New Immuno-oncology Centre of Excellence
HONG KONG, Oct 7, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group”) announced today that CerbACT Asia (Taipei, Taiwan), a Cerba Research and ACT Genomics joint venture, had unveiled its new purpose-built facility to empower precision medicine for better patient outcomes. The opening ceremony of CerbACT... » read more